O	0	10	Randomized
O	11	19	clinical
O	20	25	trial
O	26	35	comparing
B-intervention	36	40	blue
I-intervention	41	44	dye
O	45	49	with
B-control	50	58	combined
I-control	59	62	dye
I-control	63	66	and
I-control	67	74	isotope
O	75	78	for
O	79	87	sentinel
O	88	93	lymph
O	94	98	node
O	99	105	biopsy
O	106	108	in
O	109	115	breast
O	116	122	cancer
O	122	123	.

O	124	127	Use
O	128	130	of
O	131	135	blue
O	136	139	dye
O	140	145	alone
O	146	148	as
O	149	150	a
O	151	157	marker
O	158	161	for
O	162	170	sentinel
O	171	176	lymph
O	177	181	node
O	182	183	(
O	183	186	SLN
O	186	187	)
O	188	194	biopsy
O	195	197	is
O	198	207	effective
O	207	208	,
O	209	212	but
O	213	222	combining
O	223	225	it
O	226	230	with
O	231	238	isotope
O	239	246	marking
O	247	250	can
O	251	258	improve
O	259	262	the
O	263	270	success
O	271	275	rate
O	275	276	.

O	277	280	Use
O	281	283	of
O	284	287	the
O	288	295	isotope
O	296	300	adds
O	301	306	extra
O	307	311	cost
O	312	315	and
O	316	321	there
O	322	325	are
O	326	335	potential
O	336	345	radiation
O	346	353	hazards
O	353	354	.

O	355	358	The
O	359	362	two
O	363	373	techniques
O	374	378	were
O	379	387	compared
O	388	390	in
O	391	392	a
O	393	403	randomized
O	404	409	trial
O	409	410	.

B-eligibility	411	416	Women
I-eligibility	417	421	with
I-eligibility	422	427	early
I-eligibility	428	434	breast
I-eligibility	435	441	cancer
I-eligibility	442	443	(
I-eligibility	443	447	less
I-eligibility	448	452	than
I-eligibility	453	454	3
I-eligibility	455	457	cm
I-eligibility	457	458	)
I-eligibility	459	462	and
I-eligibility	463	465	no
I-eligibility	466	474	palpable
I-eligibility	475	483	axillary
I-eligibility	484	489	nodes
O	490	494	were
O	495	504	recruited
O	504	505	.

O	506	511	Women
B-age	512	517	older
I-age	518	522	than
I-age	523	525	70
I-age	526	531	years
O	532	536	with
O	537	549	multicentric
O	550	557	cancers
O	558	560	or
O	561	569	previous
O	570	577	surgery
O	578	580	to
O	581	584	the
O	585	591	breast
O	592	594	or
O	595	601	axilla
O	602	606	were
O	607	615	excluded
O	615	616	.

O	617	625	Patients
O	626	630	were
O	631	641	randomized
O	642	644	to
O	645	651	either
O	652	656	blue
O	657	660	dye
O	661	666	alone
O	667	669	or
O	670	678	combined
O	679	686	mapping
O	687	690	for
O	691	694	SLN
O	695	701	biopsy
O	701	702	.

O	703	706	All
O	707	712	women
O	713	716	had
O	717	718	a
O	719	724	level
O	725	726	I
O	727	730	and
O	731	733	II
O	734	742	axillary
O	743	753	dissection
O	754	759	after
O	760	763	the
O	764	767	SLN
O	768	774	biopsy
O	774	775	.

O	776	777	A
O	778	783	total
O	784	786	of
B-total-participants	787	790	123
O	791	799	patients
O	800	804	were
O	805	814	recruited
O	814	815	,
O	816	818	of
O	819	823	whom
O	824	828	five
O	829	833	were
O	834	842	excluded
O	843	847	from
O	848	856	analysis
O	856	857	.

O	858	862	Blue
O	863	866	dye
O	867	872	alone
O	873	876	was
O	877	881	used
O	882	884	in
B-intervention-participants	885	887	57
O	888	893	women
O	894	897	and
B-control-participants	898	900	61
O	901	904	had
O	905	913	combined
O	914	921	mapping
O	921	922	.

O	923	931	Baseline
O	932	943	demographic
O	944	948	data
O	949	953	were
O	954	961	similar
O	962	964	in
O	965	968	the
O	969	972	two
O	973	980	cohorts
O	980	981	.

O	982	985	The
B-outcome	986	993	success
I-outcome	994	998	rate
I-outcome	999	1001	of
I-outcome	1002	1005	SLN
I-outcome	1006	1012	biopsy
O	1013	1016	was
O	1017	1023	higher
O	1024	1028	with
O	1029	1037	combined
O	1038	1045	mapping
O	1046	1050	than
O	1051	1055	with
O	1056	1060	blue
O	1061	1064	dye
O	1065	1070	alone
O	1071	1072	(
B-cv-bin-percent	1072	1075	100
O	1076	1082	versus
B-iv-bin-percent	1083	1085	86
I-iv-bin-percent	1086	1089	per
I-iv-bin-percent	1090	1094	cent
O	1094	1095	;
O	1096	1097	P
O	1098	1099	=
O	1100	1101	0
O	1101	1102	.
O	1102	1105	002
O	1105	1106	)
O	1106	1107	.

O	1108	1111	The
B-outcome	1112	1120	accuracy
I-outcome	1121	1124	and
I-outcome	1125	1130	false
I-outcome	1130	1131	-
I-outcome	1131	1139	negative
I-outcome	1140	1144	rate
O	1145	1149	were
O	1150	1157	similar
O	1158	1159	(
B-outcome	1159	1167	accuracy
B-cv-bin-percent	1168	1171	100
I-cv-bin-percent	1172	1175	per
I-cv-bin-percent	1176	1180	cent
O	1181	1184	for
O	1185	1193	combined
O	1194	1201	mapping
O	1202	1208	versus
B-iv-bin-percent	1209	1211	98
I-iv-bin-percent	1212	1215	per
I-iv-bin-percent	1216	1220	cent
O	1221	1224	for
O	1225	1229	blue
O	1230	1233	dye
O	1233	1234	;
B-outcome	1235	1240	false
I-outcome	1240	1241	-
I-outcome	1241	1249	negative
I-outcome	1250	1254	rate
B-cv-bin-percent	1255	1256	0
O	1257	1263	versus
B-iv-bin-percent	1264	1265	5
I-iv-bin-percent	1266	1269	per
I-iv-bin-percent	1270	1274	cent
O	1274	1275	)
O	1275	1276	.

O	1277	1285	Combined
O	1286	1293	mapping
O	1294	1297	was
O	1298	1306	superior
O	1307	1309	to
O	1310	1314	blue
O	1315	1318	dye
O	1319	1324	alone
O	1325	1327	in
O	1328	1342	identification
O	1343	1345	of
O	1346	1349	the
O	1350	1353	SLN
O	1353	1354	,
O	1355	1358	but
O	1359	1367	accuracy
O	1368	1371	and
O	1372	1377	false
O	1377	1378	-
O	1378	1386	negative
O	1387	1392	rates
O	1393	1397	were
O	1398	1405	similar
O	1405	1406	.
